ArticleTranslational oncology2026
Prediction of local recurrence in cohorts of head and neck cancer patients after intensity-modulated radiation therapy based on CT radiomics: A double-center observation study.
Article in Translational oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to develop and validate a CT-based radiomics model for predicting the prognosis of head and neck cancer patients, particularly those with nasopharyngeal carcinoma (NPC), following intensity-modulated radiation therapy (IMRT).
methodsWe conducted a retrospective analysis involving 392 pathologically confirmed NPC patients from two centers. Center A contributed 226 patients to the training cohort, while Center B provided 64 patients for the validation cohort. Features extracted from CT images were utilized to develop two predictive models: a clinically combined radiomics model and a standalone radiomics model. Dimensionality reduction and nested cross-validation were employed in the model development process. The performance of the models was assessed and validated using receiver operating characteristic (ROC) curves and decision curve analysis (DCA), with differences between the models evaluated using the DeLong test.
resultsOur findings indicate that the clinically combined radiomics model outperforms the standalone radiomics model in prognostic prediction. The area under the curve (AUC) for the combined model was 0.90 in the training cohort, while the validation cohort achieved an AUC of 0.86. DCA further confirmed that the performance of all models exceeded that of blindly predicting patient outcomes as either all negative or all positive. Subsequent comparisons using the DeLong test revealed significant differences in predictive performance between the standalone radiomics model and the clinically combined radiomics model, with P-values <0.05.
conclusionThe clinically combined radiomics model demonstrates promising performance in predicting the prognosis of NPC patients following IMRT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.